A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in Canada
暂无分享,去创建一个
Stephen Breen | Scott Tyldesley | Jean-Pierre Bissonnette | Michael Sharpe | M. Sharpe | S. Breen | S. Tyldesley | J. Bissonnette | D. Wilke | David C Hodgson | D. Hodgson | Eman Z AlDuhaiby | Linda Mayhew | Derek R Wilke | L. Mayhew
[1] David E Morris,et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. , 2005, International journal of radiation oncology, biology, physics.
[2] C C Ling,et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.
[3] J. Staffurth,et al. A review of the clinical evidence for intensity-modulated radiotherapy. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[4] M. Koizumi,et al. Japanese structure survey of radiation oncology in 2007 based on institutional stratification of patterns of care study. , 2008, International journal of radiation oncology, biology, physics.
[5] First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] K Leszczynski,et al. Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).
[7] W. Mayles. Survey of the availability and use of advanced radiotherapy technology in the UK. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[8] J. Sham,et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.
[9] P. Warde,et al. Intensity-modulated radiotherapy in the treatment of breast cancer. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).
[10] D P Dearnaley,et al. Intensity modulated radiation therapy: a clinical review. , 2000, The British journal of radiology.
[11] John C Roeske,et al. A survey of intensity‐modulated radiation therapy use in the United States , 2003, Cancer.
[12] E. B. Butler,et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. , 2004, International journal of radiation oncology, biology, physics.
[13] G. Viani,et al. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. , 2009, International journal of radiation oncology, biology, physics.
[14] Y. Yamada,et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. , 2008, International journal of radiation oncology, biology, physics.
[15] Emma Hall,et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.
[16] Indira Madani,et al. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. , 2008, The Lancet. Oncology.
[17] J. Williamson,et al. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology". , 2008, International journal of radiation oncology, biology, physics.
[18] Indra J Das,et al. Analysis of treatment planning time among systems and planners for intensity-modulated radiation therapy. , 2009, Journal of the American College of Radiology : JACR.
[19] Mark J Dobrow,et al. Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada , 2011, BMC health services research.
[20] C. Coles,et al. A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] Norwegian Oncologists' Expectations of Intensity-modulated Radiotherapy , 2002, Acta oncologica.
[22] C. Anderson,et al. Radiation Oncology , 2001, Springer International Publishing.
[23] R. Reznek,et al. Results of a national survey of radiotherapy planning and delivery in the UK in 2007. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).
[24] Wayne Beckham,et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Geoffrey S Ibbott,et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). , 2009, International journal of radiation oncology, biology, physics.
[26] Fang-Fang Yin,et al. Advances in Technology for Intracranial Stereotactic Radiosurgery , 2009, Technology in cancer research & treatment.
[27] Richard Symonds-Tayler,et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] S. Leung,et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] M. Williams,et al. The implementation of intensity-modulated radiotherapy in the UK. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[30] L. Mell,et al. Intensity‐modulated radiation therapy use in the U.S., 2004 , 2005, Cancer.
[31] Lei Xing,et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). , 2010, International journal of radiation oncology, biology, physics.
[32] D. Kondziolka,et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.
[33] R. Wong,et al. Clinical practice guideline on the optimal radiotherapeutic management of brain metastases , 2005, BMC Cancer.
[34] K. Harrington,et al. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] N. Kemeny,et al. Colorectal hepatic metastases: adjuvant chemotherapy and survival. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.